scientific-skills/treatment-plans/references/treatment_plan_standards.md
% Treatment Plan Standards and Best Practices % Professional guidelines for treatment plan documentation % Last updated: 2025
Treatment plans are comprehensive documents that outline systematic approaches to addressing patient health conditions through evidence-based interventions, measurable goals, and structured follow-up. This reference provides professional standards, documentation requirements, and legal considerations for creating high-quality treatment plans across all medical specialties.
CRITICAL: All treatment plans MUST include a prominent "Treatment Plan Highlights" summary box on the first page.
Following the Foundation Medicine model for genomic profiling reports, treatment plans should begin with a concise, bulletin-style summary that provides immediate access to key actionable information:
Components of Treatment Plan Highlights Box:
Format Requirements:
Optimal Document Length:
Design Philosophy: The highlights box enables efficient clinical decision-making by providing critical information upfront, following evidence-based practices from precision medicine reporting. This approach improves care coordination, reduces time to treatment initiation, and ensures key information is never overlooked.
All treatment plans must include:
Short-term goals (weeks to 3 months) and long-term goals (3-12+ months) should be distinguished.
Good Example: "Reduce HbA1c from 8.5% to <7% within 3 months"
Poor Example: "Improve diabetes control"
Treatment plans must demonstrate:
Record that patient:
Enable extraction of quality metrics:
Defensible documentation includes:
For rehabilitation treatment plans:
Deficiency: "Improve diabetes"
Solution: "Reduce HbA1c from 8.5% to <7% within 3 months through medication intensification and lifestyle modification"
Deficiency: Lists medications without explanation
Solution: "Metformin 1000mg BID - first-line therapy for T2DM, reduces hepatic glucose production, target dose for HbA1c reduction"
Deficiency: Goals without timeframes
Solution: "Short-term (3 months): HbA1c <7.5%; Long-term (6 months): HbA1c <7%"
Deficiency: "Monitor labs"
Solution: "HbA1c every 3 months until at goal, then every 6 months; CMP every 6 months to monitor renal function on metformin and ACE inhibitor"
Deficiency: No documentation of education provided
Solution: Dedicated section documenting: condition education, self-management skills taught, warning signs communicated, resources provided
Deficiency: No risk mitigation
Solution: Specific safety concerns addressed (e.g., hypoglycemia risk with insulin, monitoring plan, patient taught recognition and treatment)
Scheduled Updates:
Triggered Updates:
Document Version: 1.0
Last Updated: January 2025
Next Review: January 2026